New guidance on GLP-1 use during pregnancy

Dr. Rachel Pessah-Pollack discusses new guidance from the American College of Obstetricians and Gynecologists on GLP-1 use during pregnancy.

• Oct 26

More people now use GLP-1s to lose weight than for other health issues

Growing usage of GLP-1 drugs for weight loss is reshaping how consumers shop for food and clothes, according to consulting firm EY-Parthenon.

• Oct 22

How GLP-1 drugs are changing how people shop

New research on GLP-1 drug usage from EY-Parthenon shows that weight loss is now the most popular use of the drug once dedicated to diabetes patients. CBS News' Megan Cerullo reports on how the drugs are changing spending habits for users.

• Oct 22

We tested vials sold as weight loss drugs

CBS News bought and tested vials marketed as an experimental weight loss drug from several sources to find out what was actually inside. Adam Yamaguchi shares the results on "CBS Mornings."

• Oct 21

We tested vials sold as weight loss drugs

CBS News bought and tested vials marketed as an experimental weight loss drug from several sources to find out what was actually inside. Adam Yamaguchi shares the results on "CBS Mornings."

• Oct 21

Black market weight-loss drug sparks concern

Two deaths were reported to the U.S. Food and Drug Administration that may be tied to the use of bootleg weight-loss drugs, documents reviewed by CBS News show.

• Oct 13

Can GLP-1 drugs help people stop throwing away their money?

Researchers will explore whether weight-loss drugs can deter risky or impulsive financial decisions. "It might be very good financially for the average person," one neuroscientist said.

• Oct 8

How GLP-1 drugs could help bad money habits

Dr. Carolina Haass-Koffler, associate professor of psychiatry at Brown University, joins "The Daily Report" to explain how GLP-1 drugs could be used to treat addictions beyond excessive eating.

• Oct 8

Will an FDA crackdown curb access to cheaper GLP-1 weight-loss drugs?

The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts."

• Sep 24

Can taking weight-loss drugs help you get hired? Yes, if you're a woman.

Going on GLP-1 drugs significantly boosted unemployed women's chances of finding a job, according to a Harvard economist.

• Aug 14

GLP-1 drugs may help some women get hired

A study on the use of GLP-1 drugs shows they may be helping some women get ahead in their careers. CBS MoneyWatch reporter Megan Cerullo has more.

• Aug 14

Access expanding for experimental weight loss drug

Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The company says obese patients taking the drug in clinical trials lost between 73 and 85 pounds over two years. Dr. Rachel Pessah Pollack discusses what we know about its safety, who is eligible for the medication and more.

• Aug 4

GLP-1s are linked to a 17% drop in worker sick leave, new study finds

Here's how weight-loss drugs like Ozempic and Wegovy could reduce worker illness and save companies money.

• Jul 21

Novo Nordisk sues Eli Lilly, accusing it of false advertising

The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.

• Jul 21

Medicare covering GLP-1 drugs

Medicare starts covering GLP-1 drugs on July 1. CBS News medical correspondent Dr. Céline Gounder has more.

• Jul 1

Medicare to help pay for some GLP-1 drugs

Starting Wednesday, Medicare will help pay for some GLP-1 medications for weight loss. CBS News medical correspondent Dr. Celine Gounder explains what this means for patients.

• Jul 1

Here's what to know about Medicare's new GLP-1 weight-loss drug program

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 monthly copay.

• Jun 29

Extreme heat and GLP-1 drugs

More than 10% of Americans say they use GLP-1 drugs. But experts warn some side effects from the drugs could lead to dehydration, especially in extreme heat. Nutritionist Keri Glassman explains.

• Jun 29

Benefits and risks of GLP-1 drugs for kids

Childhood and teen obesity rates have soared to record highs with about 1 in 5 living with obesity. The FDA has approved GLP-1 drugs for weight loss among kids 12 and older. Dr. Rachel Pessah-Pollack explains the risks and benefits, who may be a candidate and more.

• Jun 23

Data: Trump made 3,600 stock trades in 3 months

New data from the Office of Government Ethics shows that President Trump is ramping up his stock portfolio, with a CBS News analysis finding the president's investment accounts made 3,600 trades between January and March. CBS News senior investigative reporter Michael Kaplan has more.

• Jun 15

Trump's unprecedented levels of stock trading

A CBS News investigation shows President Trump has traded stocks at a level never before seen by an Oval Office occupant. CBS News investigative reporter Michael Kaplan has the details.

• Jun 15

Weight loss drug use during pregnancy

CBS News medical correspondent Dr. Celine Gounder breaks down findings from a new study that takes a close look at popular GLP-1 weight loss drugs and their use during early pregnancy.

• Jun 9

Dangers of unregulated weight-loss drug

Some doctors and nurses are promoting and prescribing the weight-loss drug retatrutide, which has not yet been approved by the U.S. Food and Drug Administration, a CBS News investigation found. Adam Yamaguchi has more.

• Jun 8

Doctors promote experimental weight loss drug

The weight loss drug retatrutide has been touted as "Ozempic on steroids." It's still in clinical trials and not approved by the FDA, but a CBS News investigation found that hasn't stopped doctors from offering it, and it could come with serious side effects. Adam Yamaguchi reports.

• Jun 8

The promises and pitfalls of GLP-1 drugs

Approved 20 years ago as a diabetes treatment, GLP-1 drugs have been found to help patients reduce weight, changing the lives of more than 30 million people in the U.S. But there also have been troubling side effects reported.

• Jun 7

Show More